% | $
Quotes you view appear here for quick access.

KaloBios Pharmaceuticals, Inc. Message Board

  • vanheus44 vanheus44 Sep 21, 2013 12:11 PM Flag

    The brilliance of Cross should take this to new highs soon enough!

    Hats of to KBIO management, when you bring in a winner -- it usually results in enormous upside. I think you had a classic bear raid on Friday, now expect some huge upside as KBIO breaks out. Just having Cross at the helm my deserve a double in share value from here over the next few months. The brilliance of Cross at overseeing successful monoclonal antibody therapeutic trials-- could bring KBIO as high as $50 a share in two years.

    Sentiment: Strong Buy

3.10+0.15(+5.08%)May 27 3:55 PMEDT